|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
, v0 u3 w- ~) M% J7 f2 i7 Rwas to close its brain research facility in Basel, Switzerland,
8 ~5 e2 g4 q3 qthe story noted that this move closely followed similar cuts
; U; n1 W2 Z0 ]4 P( K' n! Yby rival pharmaceutical firms. As a report from the European College
9 P0 `4 p( t- V8 vof Neuropsychopharmacology% K, [: ]) e' W7 a0 X* u
had warned a few months earlier, the; ?: M7 Z6 q/ j3 ?( ^9 O6 }2 T
abandonment of research into new psychiatric drugs by AstraZeneca,
8 D: n9 W2 m0 p# P8 AGlaxoSmithKline
) y% |- o$ Y5 s$ kand others meant that “withdrawal of research) b1 O. t- P( K6 |5 h* ~7 _2 y- a
resources is a withdrawal of hope for patients and their families”. A( f5 X$ j& ?5 P& W
" O1 Q9 |( i T
6 {2 L, P& M. U/ E0 `回复有免费下载链接( Z1 y: ?! z# S7 J, ~
$ o9 E# j6 D) F% F" b7 U$ r4 c _# R |
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
